nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—Pustule—Erlotinib—pancreatic cancer	0.061	0.189	CcSEcCtD
Amcinonide—Dermatitis acneiform—Erlotinib—pancreatic cancer	0.0242	0.0748	CcSEcCtD
Amcinonide—Telangiectasia—Fluorouracil—pancreatic cancer	0.0239	0.0741	CcSEcCtD
Amcinonide—ANXA1—gall bladder—pancreatic cancer	0.0187	0.33	CbGeAlD
Amcinonide—Leukoderma—Sunitinib—pancreatic cancer	0.0168	0.052	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Fluorouracil—pancreatic cancer	0.0161	0.0499	CcSEcCtD
Amcinonide—Folliculitis—Erlotinib—pancreatic cancer	0.0131	0.0407	CcSEcCtD
Amcinonide—ANXA1—islet of Langerhans—pancreatic cancer	0.0123	0.216	CbGeAlD
Amcinonide—Rash pustular—Erlotinib—pancreatic cancer	0.0104	0.032	CcSEcCtD
Amcinonide—Tenderness—Tamoxifen—pancreatic cancer	0.00957	0.0296	CcSEcCtD
Amcinonide—Tenderness—Erlotinib—pancreatic cancer	0.00947	0.0293	CcSEcCtD
Amcinonide—Secondary infection—Epirubicin—pancreatic cancer	0.00934	0.0289	CcSEcCtD
Amcinonide—Secondary infection—Doxorubicin—pancreatic cancer	0.00865	0.0267	CcSEcCtD
Amcinonide—ANXA1—pancreas—pancreatic cancer	0.00862	0.152	CbGeAlD
Amcinonide—ANXA1—digestive system—pancreatic cancer	0.00737	0.13	CbGeAlD
Amcinonide—Stinging—Fluorouracil—pancreatic cancer	0.00696	0.0215	CcSEcCtD
Amcinonide—Tenderness—Gemcitabine—pancreatic cancer	0.00658	0.0203	CcSEcCtD
Amcinonide—Tenderness—Fluorouracil—pancreatic cancer	0.00647	0.02	CcSEcCtD
Amcinonide—Leukoderma—Epirubicin—pancreatic cancer	0.00646	0.02	CcSEcCtD
Amcinonide—Leukoderma—Doxorubicin—pancreatic cancer	0.00598	0.0185	CcSEcCtD
Amcinonide—Dermatitis contact—Fluorouracil—pancreatic cancer	0.00557	0.0172	CcSEcCtD
Amcinonide—Folliculitis—Epirubicin—pancreatic cancer	0.00437	0.0135	CcSEcCtD
Amcinonide—NR3C1—islet of Langerhans—pancreatic cancer	0.00426	0.075	CbGeAlD
Amcinonide—Folliculitis—Doxorubicin—pancreatic cancer	0.00404	0.0125	CcSEcCtD
Amcinonide—Rash pustular—Epirubicin—pancreatic cancer	0.00344	0.0107	CcSEcCtD
Amcinonide—Stinging—Epirubicin—pancreatic cancer	0.00339	0.0105	CcSEcCtD
Amcinonide—Rash pustular—Doxorubicin—pancreatic cancer	0.00319	0.00986	CcSEcCtD
Amcinonide—Stinging—Doxorubicin—pancreatic cancer	0.00314	0.0097	CcSEcCtD
Amcinonide—NR3C1—pancreas—pancreatic cancer	0.003	0.0527	CbGeAlD
Amcinonide—Infection—Tamoxifen—pancreatic cancer	0.00296	0.00915	CcSEcCtD
Amcinonide—Infection—Erlotinib—pancreatic cancer	0.00293	0.00906	CcSEcCtD
Amcinonide—Dermatitis contact—Epirubicin—pancreatic cancer	0.00271	0.0084	CcSEcCtD
Amcinonide—NR3C1—digestive system—pancreatic cancer	0.00256	0.045	CbGeAlD
Amcinonide—Pain—Tamoxifen—pancreatic cancer	0.00255	0.00788	CcSEcCtD
Amcinonide—Infection—Sunitinib—pancreatic cancer	0.00253	0.00784	CcSEcCtD
Amcinonide—Pain—Erlotinib—pancreatic cancer	0.00252	0.0078	CcSEcCtD
Amcinonide—Dermatitis contact—Doxorubicin—pancreatic cancer	0.00251	0.00777	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—GLP1R—pancreatic cancer	0.00243	0.00391	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CNR2—pancreatic cancer	0.00243	0.00391	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.0024	0.00387	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CCKAR—pancreatic cancer	0.00239	0.00385	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.00229	0.00369	CbGpPWpGaD
Amcinonide—Pain—Sunitinib—pancreatic cancer	0.00218	0.00675	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—SHH—pancreatic cancer	0.00218	0.00351	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—PTGS2—pancreatic cancer	0.00217	0.0035	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.00217	0.0035	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PRLHR—pancreatic cancer	0.00217	0.0035	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.00216	0.00349	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—PPARG—pancreatic cancer	0.00216	0.00348	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—IAPP—pancreatic cancer	0.00215	0.00347	CbGpPWpGaD
Amcinonide—Pruritus—Tamoxifen—pancreatic cancer	0.00211	0.00652	CcSEcCtD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.00211	0.0034	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CXCL8—pancreatic cancer	0.00211	0.0034	CbGpPWpGaD
Amcinonide—Infection—Irinotecan—pancreatic cancer	0.00209	0.00646	CcSEcCtD
Amcinonide—NR3C1—Adipogenesis—AHR—pancreatic cancer	0.00209	0.00337	CbGpPWpGaD
Amcinonide—Pruritus—Erlotinib—pancreatic cancer	0.00208	0.00645	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—PTHLH—pancreatic cancer	0.00206	0.00333	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—PTCH1—pancreatic cancer	0.00206	0.00333	CbGpPWpGaD
Amcinonide—Infection—Gemcitabine—pancreatic cancer	0.00203	0.00629	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—SSTR3—pancreatic cancer	0.00203	0.00327	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CASP3—pancreatic cancer	0.00202	0.00325	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.00201	0.00324	CbGpPWpGaD
Amcinonide—Infection—Fluorouracil—pancreatic cancer	0.002	0.00619	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—GDI2—pancreatic cancer	0.00199	0.00321	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GDI1—pancreatic cancer	0.00199	0.00321	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CCND1—pancreatic cancer	0.00196	0.00317	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—SMAD4—pancreatic cancer	0.00195	0.00314	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00195	0.00314	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.00192	0.0031	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PPY—pancreatic cancer	0.00191	0.00308	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MMP9—pancreatic cancer	0.00191	0.00307	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.00189	0.00305	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—HIF1A—pancreatic cancer	0.00189	0.00305	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—SST—pancreatic cancer	0.00189	0.00304	CbGpPWpGaD
Amcinonide—Dermatitis—Tamoxifen—pancreatic cancer	0.00188	0.0058	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.00187	0.00302	CbGpPWpGaD
Amcinonide—Dermatitis—Erlotinib—pancreatic cancer	0.00186	0.00574	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—SSTR3—pancreatic cancer	0.00184	0.00297	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.00181	0.00292	CbGpPWpGaD
Amcinonide—Pruritus—Sunitinib—pancreatic cancer	0.0018	0.00558	CcSEcCtD
Amcinonide—Pain—Irinotecan—pancreatic cancer	0.0018	0.00556	CcSEcCtD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—pancreatic cancer	0.00178	0.00287	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—SSTR1—pancreatic cancer	0.00177	0.00285	CbGpPWpGaD
Amcinonide—Pain—Gemcitabine—pancreatic cancer	0.00175	0.00542	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—CNR1—pancreatic cancer	0.00174	0.00281	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PPY—pancreatic cancer	0.00173	0.0028	CbGpPWpGaD
Amcinonide—Pain—Fluorouracil—pancreatic cancer	0.00172	0.00532	CcSEcCtD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00171	0.00275	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—SSTR2—pancreatic cancer	0.0017	0.00274	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.00169	0.00273	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—GCG—pancreatic cancer	0.00168	0.00271	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.00166	0.00267	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCKBR—pancreatic cancer	0.00164	0.00265	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.00161	0.0026	CbGpPWpGaD
Amcinonide—Dermatitis—Sunitinib—pancreatic cancer	0.00161	0.00497	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—AGTR1—pancreatic cancer	0.0016	0.00259	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.0016	0.00257	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MYC—pancreatic cancer	0.00157	0.00254	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TGFB1—pancreatic cancer	0.00157	0.00253	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—HIF1A—pancreatic cancer	0.00156	0.00251	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GAST—pancreatic cancer	0.00156	0.00251	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.00156	0.00251	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—GADD45A—pancreatic cancer	0.00155	0.0025	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PLAU—pancreatic cancer	0.00154	0.00249	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—EGFR—pancreatic cancer	0.00154	0.00248	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.00148	0.00238	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—SCT—pancreatic cancer	0.00147	0.00238	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—pancreatic cancer	0.00147	0.00237	CbGpPWpGaD
Amcinonide—Pruritus—Gemcitabine—pancreatic cancer	0.00145	0.00448	CcSEcCtD
Amcinonide—Infection—Docetaxel—pancreatic cancer	0.00144	0.00446	CcSEcCtD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL8—pancreatic cancer	0.00144	0.00232	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—NOTCH1—pancreatic cancer	0.00144	0.00232	CbGpPWpGaD
Amcinonide—Pruritus—Fluorouracil—pancreatic cancer	0.00142	0.0044	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—GAST—pancreatic cancer	0.00141	0.00228	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCK—pancreatic cancer	0.00141	0.00227	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.0014	0.00227	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.00137	0.00221	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.00137	0.00221	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CNR2—pancreatic cancer	0.00137	0.00221	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.00137	0.0022	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.00135	0.00218	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—SCT—pancreatic cancer	0.00134	0.00216	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.00134	0.00215	CbGpPWpGaD
Amcinonide—Dermatitis—Irinotecan—pancreatic cancer	0.00132	0.00409	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.00132	0.00213	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—pancreatic cancer	0.00129	0.00209	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.00129	0.00208	CbGpPWpGaD
Amcinonide—Dermatitis—Gemcitabine—pancreatic cancer	0.00129	0.00399	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.00129	0.00208	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRLHR—pancreatic cancer	0.00128	0.00207	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CCK—pancreatic cancer	0.00128	0.00206	CbGpPWpGaD
Amcinonide—Dermatitis—Fluorouracil—pancreatic cancer	0.00127	0.00392	CcSEcCtD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.00126	0.00204	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CNR2—pancreatic cancer	0.00124	0.00201	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GLP1R—pancreatic cancer	0.00124	0.00201	CbGpPWpGaD
Amcinonide—Pain—Docetaxel—pancreatic cancer	0.00124	0.00384	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—CCKAR—pancreatic cancer	0.00122	0.00198	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00122	0.00196	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IAPP—pancreatic cancer	0.00121	0.00196	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.00121	0.00196	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ZNRF3—pancreatic cancer	0.0012	0.00194	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ACVR1B—pancreatic cancer	0.0012	0.00194	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.00119	0.00193	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.00119	0.00193	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.00117	0.00188	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.00116	0.00188	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—SHH—pancreatic cancer	0.00112	0.0018	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN2A—pancreatic cancer	0.00111	0.0018	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IAPP—pancreatic cancer	0.0011	0.00178	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SSTR3—pancreatic cancer	0.00109	0.00176	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DTX1—pancreatic cancer	0.00109	0.00176	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.00107	0.00173	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.00107	0.00172	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—SST—pancreatic cancer	0.00107	0.00172	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.00106	0.00171	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PTHLH—pancreatic cancer	0.00106	0.00171	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PTCH1—pancreatic cancer	0.00106	0.00171	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.00105	0.0017	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.00105	0.00169	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.00105	0.00169	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SSTR1—pancreatic cancer	0.00104	0.00168	CbGpPWpGaD
Amcinonide—Pruritus—Docetaxel—pancreatic cancer	0.00103	0.00318	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—PPY—pancreatic cancer	0.00102	0.00165	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CXCL8—pancreatic cancer	0.00101	0.00163	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SSTR2—pancreatic cancer	0.001	0.00162	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000997	0.00161	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000989	0.0016	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000984	0.00159	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.00098	0.00158	CbGpPWpGaD
Amcinonide—Infection—Epirubicin—pancreatic cancer	0.000973	0.00301	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—CCKBR—pancreatic cancer	0.00097	0.00157	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—SST—pancreatic cancer	0.000968	0.00156	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000965	0.00156	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—CTNNB1—pancreatic cancer	0.000955	0.00154	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.000953	0.00154	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GCG—pancreatic cancer	0.00095	0.00153	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—HIF1A—pancreatic cancer	0.00095	0.00153	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCND1—pancreatic cancer	0.000942	0.00152	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CTNNB1—pancreatic cancer	0.000933	0.0015	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.000925	0.00149	CbGpPWpGaD
Amcinonide—Dermatitis—Docetaxel—pancreatic cancer	0.000915	0.00283	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—pancreatic cancer	0.000914	0.00147	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GLI1—pancreatic cancer	0.000912	0.00147	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—DTX4—pancreatic cancer	0.000912	0.00147	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PTEN—pancreatic cancer	0.000909	0.00147	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000909	0.00147	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000907	0.00146	CbGpPWpGaD
Amcinonide—Infection—Doxorubicin—pancreatic cancer	0.000901	0.00279	CcSEcCtD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.0009	0.00145	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000896	0.00145	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CNR1—pancreatic cancer	0.000894	0.00144	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—pancreatic cancer	0.000891	0.00144	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRP1—pancreatic cancer	0.000888	0.00143	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000888	0.00143	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000879	0.00142	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GCG—pancreatic cancer	0.000863	0.00139	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HEY2—pancreatic cancer	0.000854	0.00138	CbGpPWpGaD
Amcinonide—Pain—Epirubicin—pancreatic cancer	0.000838	0.00259	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—GAST—pancreatic cancer	0.000835	0.00135	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000827	0.00133	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000823	0.00133	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000821	0.00132	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARG—pancreatic cancer	0.000808	0.0013	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SCT—pancreatic cancer	0.000791	0.00128	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HEY1—pancreatic cancer	0.000791	0.00128	CbGpPWpGaD
Amcinonide—Pain—Doxorubicin—pancreatic cancer	0.000775	0.0024	CcSEcCtD
Amcinonide—NR3C1—Adipogenesis—RB1—pancreatic cancer	0.000773	0.00125	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—TGFB1—pancreatic cancer	0.000771	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000765	0.00123	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.00076	0.00123	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MYC—pancreatic cancer	0.000755	0.00122	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCK—pancreatic cancer	0.000755	0.00122	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TGFB1—pancreatic cancer	0.000754	0.00122	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000743	0.0012	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CNR2—pancreatic cancer	0.000735	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GLP1R—pancreatic cancer	0.000735	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000735	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCKAR—pancreatic cancer	0.000724	0.00117	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JAG2—pancreatic cancer	0.000702	0.00113	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CHD3—pancreatic cancer	0.000698	0.00113	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000698	0.00113	CbGpPWpGaD
Amcinonide—Pruritus—Epirubicin—pancreatic cancer	0.000693	0.00214	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—MEN1—pancreatic cancer	0.000691	0.00112	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000672	0.00108	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000662	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SHH—pancreatic cancer	0.00066	0.00106	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000656	0.00106	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IAPP—pancreatic cancer	0.000651	0.00105	CbGpPWpGaD
Amcinonide—Pruritus—Doxorubicin—pancreatic cancer	0.000641	0.00198	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—PTHLH—pancreatic cancer	0.000625	0.00101	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTCH1—pancreatic cancer	0.000625	0.00101	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—pancreatic cancer	0.00062	0.001	CbGpPWpGaD
Amcinonide—Dermatitis—Epirubicin—pancreatic cancer	0.000617	0.00191	CcSEcCtD
Amcinonide—NR3C1—Gene Expression—NR5A2—pancreatic cancer	0.000585	0.000944	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SST—pancreatic cancer	0.000572	0.000923	CbGpPWpGaD
Amcinonide—Dermatitis—Doxorubicin—pancreatic cancer	0.000571	0.00177	CcSEcCtD
Amcinonide—NR3C1—Adipogenesis—CTNNB1—pancreatic cancer	0.000568	0.000917	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000564	0.00091	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000563	0.000908	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JAG1—pancreatic cancer	0.00056	0.000903	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000557	0.000899	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—pancreatic cancer	0.000547	0.000882	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.000532	0.000859	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CNR1—pancreatic cancer	0.000528	0.000851	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000512	0.000826	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GCG—pancreatic cancer	0.00051	0.000822	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.00051	0.000822	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000496	0.0008	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—STAT3—pancreatic cancer	0.000495	0.000799	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000491	0.000792	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGTR1—pancreatic cancer	0.000486	0.000784	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STK11—pancreatic cancer	0.000479	0.000773	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000466	0.000752	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	0.000462	0.000745	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TGFB1—pancreatic cancer	0.000459	0.000741	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.00045	0.000726	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000432	0.000698	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000432	0.000697	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—pancreatic cancer	0.000429	0.000692	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000424	0.000684	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SMAD4—pancreatic cancer	0.00042	0.000677	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000415	0.00067	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HES1—pancreatic cancer	0.00041	0.000661	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000393	0.000633	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000377	0.000608	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000371	0.000598	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TERT—pancreatic cancer	0.000359	0.000579	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HIF1A—pancreatic cancer	0.000343	0.000554	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TSC2—pancreatic cancer	0.000343	0.000553	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MEN1—pancreatic cancer	0.000336	0.000542	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOE—pancreatic cancer	0.000335	0.000541	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KDR—pancreatic cancer	0.000329	0.00053	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	0.000319	0.000514	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000312	0.000504	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000312	0.000504	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000309	0.000499	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	0.000304	0.00049	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000303	0.000488	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NRAS—pancreatic cancer	0.000303	0.000488	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGF—pancreatic cancer	0.000299	0.000482	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000295	0.000476	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EZH2—pancreatic cancer	0.000277	0.000446	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EGFR—pancreatic cancer	0.000276	0.000445	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	0.000271	0.000437	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000266	0.000429	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000264	0.000425	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KRAS—pancreatic cancer	0.00026	0.00042	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	0.000257	0.000414	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000239	0.000386	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CB—pancreatic cancer	0.000232	0.000374	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—pancreatic cancer	0.000223	0.000359	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRAS—pancreatic cancer	0.000221	0.000357	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AKT1—pancreatic cancer	0.000215	0.000347	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CASP3—pancreatic cancer	0.000213	0.000344	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCND1—pancreatic cancer	0.000208	0.000335	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CTNNB1—pancreatic cancer	0.000206	0.000332	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SMAD4—pancreatic cancer	0.000204	0.000329	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—pancreatic cancer	0.000202	0.000325	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PTEN—pancreatic cancer	0.0002	0.000323	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AKT1—pancreatic cancer	0.000195	0.000315	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SRC—pancreatic cancer	0.000186	0.0003	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—pancreatic cancer	0.000181	0.000292	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STAT3—pancreatic cancer	0.000179	0.000289	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRAS—pancreatic cancer	0.000179	0.000288	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	0.000168	0.000271	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MYC—pancreatic cancer	0.000167	0.000269	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFB1—pancreatic cancer	0.000166	0.000268	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGFR—pancreatic cancer	0.000163	0.000263	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KRAS—pancreatic cancer	0.000154	0.000248	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	0.00015	0.000243	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARG—pancreatic cancer	0.000142	0.000229	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CA—pancreatic cancer	0.000141	0.000228	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—pancreatic cancer	0.000137	0.000221	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRAS—pancreatic cancer	0.000131	0.000211	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKT1—pancreatic cancer	0.000115	0.000186	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MYC—pancreatic cancer	8.09e-05	0.000131	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—AKT1—pancreatic cancer	5.61e-05	9.05e-05	CbGpPWpGaD
